John Stamos celebrated his son Billy's 7th birthday — and his wife Caitlin McHugh who welcomed him into the world — with a ...

Hims & Hers Health, Inc. (HIMS) ended the recent trading session at $27.23, demonstrating a +1.04% swing from the preceding day's closing price. This change outpaced the S&P 500's 0.13% gain on the ...

My 92-year-old mom's politically engaged, widely read, a clothes horse and a quick draw with a cocktail shaker. Here's how ...

A bride-to-be is questioning her friendship with one of her closest friends after she reacted negatively to their weddings ...

HIMS has experienced similar dramatic drops before. During the 2022 inflation surge, the stock fell 87%, and in 2020, it ...

Rita and Richard Zajko were found shot in the head, execution-style, in their home in Chester Heights on Dec. 31, 2022.

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Telehealth platform Hims & Hers Health, Inc. (HIMS), which connects consumers to healthcare professionals, is at a crossroads ...

The Justice Department under Attorney General Pam Bondi faces naby lawsuits over deportations and other Trump policies even ...

Shares of Hims & Hers Health ( HIMS 12.82%) surged on Tuesday, closing the session up 5.25% after having been up by as much as 14% earlier. That jump came as the S&P 500 and Nasdaq Composite showed ...

The telehealth-consultation platform said it plans to continue expanding its weight loss offerings.

Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment Mounjaro to its telehealth platform.